Cargando…

Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia

OBJECTIVES: To compare the 30-day outcome (mortality and/or ICU admission) of patients admitted for moderate-severe SARS-CoV-2 pneumonia treated with dexamethasone after the Recovery study versus those treated with weight-adjusted methylprednisolone. METHODS: Retrospective cohort study of 65 patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aomar-Millán, Ismael F., Fatoul-del Pino, Geoorgette, Torres-Parejo, Úrsula, Pérez Fernández, Laura, Martínez-Diz, Silvia, Salvatierra, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870753/ https://www.ncbi.nlm.nih.gov/pubmed/36713976 http://dx.doi.org/10.1016/j.medcle.2023.01.002

Ejemplares similares

Dexametasona frente a metilprednisolona ajustada al peso en pacientes con neumonía moderada-grave por SARS-CoV-2
por: Aomar-Millán, Ismael F., et al.
Publicado: (2023)

Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Characteristics and clinical outcome in 312 patients with moderate to severe pneumonia due to SARS-COV-2 and hyperinflammation treated with anakinra and corticosteroids: A retrospective cohort study
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2023)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Aomar-Millán, Ismael F., et al.
Publicado: (2022)

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Glucocorticoides solos versus tocilizumab solo o glucocorticoides más tocilizumab en pacientes con neumonía grave por SARS-CoV-2 e inflamación moderada
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Pulse dexamethasone therapy versus pulse methylprednisolone therapy for treatment of Graves's ophthalmopathy
por: Philip, Rajeev, et al.
Publicado: (2013)

Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia
por: Pinzón, Miguel Alejandro, et al.
Publicado: (2021)

Comparison of efficacy of dexamethasone and methylprednisolone in moderate to severe covid 19 disease
por: Fatima, Syeda Arzinda, et al.
Publicado: (2020)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation
por: Salvatierra, Juan, et al.
Publicado: (2021)

Efecto del tocilizumab frente a cuidado estándar en pacientes adultos hospitalizados con neumonía por COVID-19 moderada-grave
por: Aomar-Millán, Ismael F., et al.
Publicado: (2022)

Caution with the use of dexamethasone in patients with COVID-19 in its initial phases()
por: Callejas Rubio, J.L., et al.
Publicado: (2021)

Dexamethasone/hydrocortisone/methylprednisolone: Disseminated cryptococcosis following off label use of dexamethasone, hydrocortisone and methylprednisolone: case report
Publicado: (2022)

Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab: comentario
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2023)

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2023)

Skeletal Muscle Response to Deflazacort, Dexamethasone and Methylprednisolone
por: Fappi, Alan, et al.
Publicado: (2019)

Dexamethasone/methylprednisolone/prednisolone: Psychosis: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Various toxicities: case report
Publicado: (2022)

Dexamethasone/methylprednisolone/tocilizumab: Candidaemia: case report
Publicado: (2021)

Dexamethasone or methylprednisolone therapy in covid-19 pneumonia: A retrospective and comparative study of 513 cases
por: El mezzeoui, Sanae, et al.
Publicado: (2021)

Dexamethasone/methylprednisolone: Various toxicities: 2 case reports
Publicado: (2020)

Dexamethasone/methylprednisolone/steroids: Hypertension: 2 case reports
Publicado: (2021)

Dexamethasone/eltrombopag/methylprednisolone: Lack of efficacy: 2 case reports
Publicado: (2022)

Dexamethasone/methylprednisolone: Mucormycosis and gastrointestinal mucormycosis: 7 case reports
Publicado: (2022)

Comparison between Dexamethasone and Methylprednisolone Therapy in Patients with COVID-19 Pneumonia Admitted to Non-Intensive Medical Units
por: Buso, Roberta, et al.
Publicado: (2021)

Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)
por: Salton, Francesco, et al.
Publicado: (2023)

Dexamethasone to the rescue
por: Moon, Chang
Publicado: (2020)

Methylprednisolone versus Dexamethasone for Control of Vertigo in Patients with Definite Meniere's disease
por: Masoumi, Elham, et al.
Publicado: (2017)

Antibacterials/dexamethasone/methylprednisolone: Suspected invasive bronchopulmonary aspergillosis: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Off label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/methylprednisolone: Off-label use and cryptococcal meningoencephalitis: case report
Publicado: (2022)

Methylprednisolone: Rebound pneumonia: case report
Publicado: (2022)

Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis
por: Menon, Vimala, et al.
Publicado: (2007)

Azithromycin/dexamethasone/methylprednisolone: Aspergillosis, mucormycosis and off-label use: case report
Publicado: (2022)

Dexamethasone/methylprednisolone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Pulse Methylprednisolone Versus Dexamethasone in COVID-19: A Multicenter Cohort Study
por: Watanabe, Atsuyuki, et al.
Publicado: (2023)

Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children
por: Tamura, Akihiro, et al.
Publicado: (2008)

Dexamethasone in patients with diabetes mellitus
por: Greenhill, Claire
Publicado: (2022)

In Search of a Better Option: Dexamethasone Versus Methylprednisolone in Third Molar Impaction Surgery
por: Darawade, Dattatraya A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0aoa80u2s4645ipdbqt9ccipml